×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
×
Close
CN1699 Our Business - Guide for Agents
分类
Hematology
4513
Global Medical University
3618
Allergy
1540
Anatomy & Morphology
1308
Andrology
414
Anesthesia & Intensive Care
898
Anesthesiology
4050
Audiology & Speech-Language Pathology
299
Behavioral Sciences
80
Biochemical Research Methods
5000
Biochemistry & Molecular Biology
23452
Biodiversity Conservation
212
Biology
6066
Biophysics
5561
Biotechnology & Applied Microbiology
6242
Cardiac & Cardiovascular Systems
24385
Cardiovascular & Respiratory Systems
1137
Cell & Tissue Engineering
500
Cell Biology
9119
Chemistry, Analytical
3576
Chemistry, Applied
8849
Chemistry, Medicinal
7090
Chemistry, Multidisciplinary
15609
Clinical Immunology & Infectious Disease
342
Clinical Medicine
7678
Clinical Neurology
12672
Clinical Psychology & Psychiatry
778
Critical Care Medicine
2276
Dentistry, Oral Surgery & Medicine
9966
Dermatology
6890
Developmental Biology
5883
Ecology
610
Education, Scientific Disciplines
1415
Emergency Medicine
2990
Endocrinology, Metabolism & Nutrition
18163
Engineering, Biomedical
2858
Entomology
316
Environmental Medicine & Public Health
3543
Evolutionary Biology
192
Gastroenterology & Hepatology
9117
General & Internal Medicine
5338
Genetics & Heredity
11479
Geriatrics & Gerontology
3992
Gerontology
258
Health Care Sciences & Services
11884
Health Policy & Services
469
Immunology
19452
Infectious Diseases
10696
Integrative & Complementary Medicine
1893
Medical Ethics
825
Medical Informatics
1530
Medical Laboratory Technology
429
Medicine, General & Internal
36319
Medicine, Legal
313
Medicine, Research & Experimental
13291
Microbiology
17797
Mycology
0
Nanoscience & Nanotechnology
3909
Neuroimaging
937
Neurology
3273
Neurosciences
30078
Nursing
7355
Nutrition & Dietetics
6897
Obstetrics & Gynecology
6307
Oncology
41322
Ophthalmology
7120
Optics
2908
Orthopedics
8646
Orthopedics, Rehabilitation & Sports Medicine
1231
Otolaryngology
1237
Otorhinolaryngology
3990
Parasitology
755
Pathology
3771
Pediatrics
16363
Peripheral Vascular Disease
3588
Pharmacology & Pharmacy
25177
Pharmacology/Toxicology
9804
Physiology
7392
Polymer Science
423
Primary Health Care
633
Psychiatry
14108
Psychology
4062
Psychology, Applied
64
Psychology, Biological
238
Psychology, Clinical
597
Psychology, Developmental
176
Psychology, Educational
89
Psychology, Experimental
85
Psychology, Mathematical
0
Psychology, Multidisciplinary
1289
Psychology, Psychoanalysis
41
Psychology, Social
78
Public Health & Health Care Science
1868
Public, Environmental & Occupational Health
21889
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
9158
Radiology, Nuclear Medicine & Medical Imaging
6345
Rehabilitation
2515
Remote Sensing
0
Reproductive Biology
1953
Reproductive Medicine
850
Research/Laboratory Medicine & Medical Technology
2880
Respiratory System
5445
Rheumatology
4336
Social Sciences, Biomedical
1015
Substance Abuse
2129
Surgery
25115
Toxicology
3517
Transplantation
770
Tropical Medicine
274
Urology & Nephrology
9813
Veterinary Sciences
35
Virology
1834
Zoology
0
渠道
BLOOD CANCER JOURNAL
309
Hematology\Oncology
3
Medrxiv - Hematology
114
AMERICAN JOURNAL OF HEMATOLOGY
248
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
20
BRITISH JOURNAL OF HAEMATOLOGY
460
CIRCULATION RESEARCH
383
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
373
HAEMOPHILIA
143
JOURNAL OF CLINICAL APHERESIS
57
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
258
LANCET HAEMATOLOGY
29
THERAPEUTIC ADVANCES IN HEMATOLOGY
35
ACTA HAEMATOLOGICA
152
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
93
BLOOD COAGULATION & FIBRINOLYSIS
33
BLOOD PURIFICATION
179
CURRENT OPINION IN HEMATOLOGY
34
EUROPEAN JOURNAL OF HAEMATOLOGY
95
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
148
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
231
HAMOSTASEOLOGIE
115
ASIAN JOURNAL OF TRANSFUSION SCIENCE
20
EGYPTIAN JOURNAL OF HAEMATOLOGY
35
HEMASPHERE
275
HEMATOLOGY REPORTS
17
IRAQI JOURNAL OF HEMATOLOGY
69
CURRENT HEMATOLOGIC MALIGNANCY REPORTS
73
INTERNATIONAL JOURNAL OF HEMATOLOGY
427
JOURNAL OF HEMATOPATHOLOGY
85
SCI时时刷
search
全部
推荐
+
Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma
Multiple Myeloma (MM) is characterized by a great clinical and genetic heterogeneity [1]. The disease rem...
Blood Cancer Journal
comment
0
thumb_up
0
ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias
Deletion of ABL1 was detected in a cohort of hematologic malignancies carrying AML1-ETO and NUP98 fusion proteins. Abl1...
Blood Cancer Journal
comment
0
thumb_up
0
CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study
Giebel S, Marks DI, Boissel N, Baron F, Chiaretti S, Ciceri F, et al. Hematopoietic stem cell transplantation for adults w...
Blood Cancer Journal
comment
0
thumb_up
0
Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study
Bortezomib, lenalidomide, and dexamethasone induction chemotherapy (VRd), followed by autologous stem cell transplantation...
Blood Cancer Journal
comment
0
thumb_up
0
Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
Almost all patients with multiple myeloma (MM) will eventually develop disease that has relapsed with or become refractory...
Blood Cancer Journal
comment
0
thumb_up
0
Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
Faculty of Medicine, Univeristy of Iceland, Reykjavík, IcelandSæmundur Rögnvaldsson, Thorvardur Jon Love, Sigrun Thorstein...
Blood Cancer Journal
comment
0
thumb_up
0
Multiple myeloma with t(11;14): impact of novel agents on outcome
Multiple myeloma (MM) patients with t(11;14) present unique biological features and their prognosis is not well establishe...
Blood Cancer Journal
comment
0
thumb_up
0
Current CML guidelines overemphasize second generation TKIs: revisiting the paradigm
The basis of the NCCN recommendation is that 2G-TKIs lead to improved molecular and cytogenetic responses in CML patients....
Blood Cancer Journal
comment
0
thumb_up
0
MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas
The paracaspase mucosa-associated lymphoid tissue 1 (MALT1) is a protease and scaffold protein essential in propagating B-...
Blood Cancer Journal
comment
0
thumb_up
0
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic
The COVID-19 pandemic has had global healthcare impacts, including high mortality from SARS-CoV-2 infection in cancer pati...
Blood Cancer Journal
comment
0
thumb_up
0
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), formerly known as agranular CD4+/CD56+ hematodermic...
Blood Cancer Journal
comment
0
thumb_up
0
Infectious complications of bispecific antibody therapy in patients with multiple myeloma
We identified 39 MM patients who received BsAb therapy at our centre with median follow-up of 152 (IQR 51–277) days. The m...
Blood Cancer Journal
comment
0
thumb_up
0
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS
Competing interests PM received honoraria from Bristol Myers Squibb/Celgen...
Blood Cancer Journal
comment
0
thumb_up
0
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients
Minimal residual disease (MRD) assays allow response assessment in patients with multiple myeloma (MM), and negativity is ...
Blood Cancer Journal
comment
0
thumb_up
0
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy
Thrombotic microangiopathy (TMA) has been reported to occur in multiple myeloma (MM) patients in association with treatmen...
Blood Cancer Journal
comment
0
thumb_up
0
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry
Minimal residual disease (MRD) assessment has been established as a prognostic indicator for multiple mye...
Blood Cancer Journal
comment
0
thumb_up
0
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience
Competing interests MD serves as Consultant for Amgen, Celgene, Janssen, K...
Blood Cancer Journal
comment
0
thumb_up
0
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases
Blast-phase transformation in myeloproliferative neoplasms (MPN-BP) occurs at rates of 3.9, 2.6, and 9.3%...
Blood Cancer Journal
comment
0
thumb_up
0
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance
Monoclonal gammopathy of undetermined significance (MGUS) is a benign hematological condition with the potential to progre...
Blood Cancer Journal
comment
0
thumb_up
0
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations
Constant challenges for the treatment of mantle cell lymphoma (MCL) remain to be recurrent relapses and therapy resistance...
Blood Cancer Journal
comment
0
thumb_up
0
Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
Multiple myeloma (MM), an incurable plasma cell malignancy, is the second most common form of blood cance...
Blood Cancer Journal
comment
0
thumb_up
0
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
These authors contributed equally: Keiji Kurata, Anna James-Bott.Jerome Lipper Multiple Myeloma Center, LeBow Institute fo...
Blood Cancer Journal
comment
0
thumb_up
0
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors
PI3Kδ inhibitors are approved for the therapy of B cell malignancies, but their clinical use has been limited by unpr...
Blood Cancer Journal
comment
0
thumb_up
0
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics
Novel drug discoveries have shifted the treatment paradigms of most hematological malignancies, including multiple myeloma...
Blood Cancer Journal
comment
0
thumb_up
0
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis
Somatic mutations in calreticulin (CALR), encoding for the reticulum-endoplasmic-associated Ca2+-binding ...
Blood Cancer Journal
comment
0
thumb_up
0
Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
Functional perturbations of the cohesin complex with subsequent changes in chromatin structure and replication are reporte...
Blood Cancer Journal
comment
0
thumb_up
0
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018
Systemic light-chain (AL) amyloidosis is a rare and debilitating disease. Advances have been made in new treatments in rec...
Blood Cancer Journal
comment
0
thumb_up
0
DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease
While chemoimmunotherapy has been the standard treatment for chronic lymphocytic leukemia (CLL), it has b...
Blood Cancer Journal
comment
0
thumb_up
0
Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
Patients with hematologic diseases receiving anti-CD20 monoclonal antibodies show a low seroconversion ra...
Blood Cancer Journal
comment
0
thumb_up
0
Alternative splicing in multiple myeloma is associated with the non-homologous end joining pathway
Alternative splicing plays a pivotal role in tumorigenesis and proliferation. However, its pattern and pathogenic role has...
Blood Cancer Journal
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin